Driving research of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS),
Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia and Long COVID.

Don’t miss out! 3X the impact on research

“I once chased the perfect wave. Now, I chase the hope for a cure.” 

 

Robert had to stop his passion of surfing, traveling, and working towards a promising business career because of ME/CFS. He says, “When I wasn’t surfing, I was working towards a business career and had three great job offers.” He even played classical piano. Robert believes that with our support, there is hope for a cure.

 

He believes in OMF, just like we do. Robert knows that OMF’s passionate and expert team of scientists are working urgently to find answers. He says, “Right now is an exciting time. We have some of the best minds working on this problem and they are making steady progress to find answers.”

 

Robert’s hope shines bright. He shares, “If you look back on history, you will find many instances where things were considered ‘impossible’ until a group of great minds figured it out. I think the problem of ME/CFS and chronic complex disease is no different.”

 

There is only a week left of Triple Giving November, where ALL donations to OMF are tripled up to $500,000 thanks to generous matching donors. Hurry! The match ends on November 30, 2023.

 

“I have faith that through OMF and OMFCA, great scientists will find answers
to solve the ‘impossible’ and the cure for ME/CFS will be discovered.” – Robert
 

Can we count on your support? Your donation, big or small, will make 3x the impact if given before November 30. Let’s make history together and add the cure for ME/CFS to the list of impossible things made possible by people like you.

 

PS: November 27 is Stock Monday! Take action and triple the impact of your appreciated stock by donating directly to OMCA here. (Click “transfer stock.”) You can receive an immediate income-tax deduction for the fair market value of the securities on the date of transfer. Put your investments to work for ME/CFS and Long COVID research.